openPR Logo
Press release

Atopic Dermatitis Treatment Market | SWOT Analysis of Major Market Segments

07-05-2018 08:19 PM CET | Health & Medicine

Press release from: Transparency Market Research

Atopic Dermatitis Treatment Market | SWOT Analysis of Major

Atopic dermatitis (AD) is a type of skin disorder in which the skin becomes dry, itchy and inflamed. Scratching of the skin leads to redness, swelling, scaling, cracking, weeping and crusting. Though, this condition is most common in infants and children, also affects adult population. AD is considered as idiopathic, a disease without a known cause, and is likely to be caused by both genetic as well as environmental factors. Many persons with AD have been found with a family history of atopy. People living in dry climate are more likely to get affected. Generally, people with AD develop asthma and hay fever.

Topical steroids are currently the mainstay of treatment of atopic dermatitis and hold the largest segment of the overall Atopic Dermatitis Treatment Market. A five minute lukewarm baths followed by the application of a moisturizer is also beneficial in treating patients suffering from AD. Immunomodulators such as tacrolimus and Pimecrolimus are too used to treat AD. The global market for atopic dermatitis treatment will be majorly driven by new product launch in coming years.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2125

The anticipated launch of dupilumab, a monoclonal antibody being developed by Sanofi and Regeneron Pharmaceuticals, Inc. for treating atopic diseases is expected to play a major role in driving the growth of atopic dermatitis treatment market across the globe. Side effects associated with drugs used in the treatment of AD are one of the major reasons hampering the market growth. The market offers opportunities for companies engaged in developing novel systemic therapies as there is a considerable need for medications with enhanced safety and efficacy profiles.

The number of patients suffering from atopic dermatitis has significantly increased during the last three decades. According to the National Eczema Association (NEA), AD affects nearly 10% to 20% of infants in the U.S. In Asia-Pacific, India and China are the major countries accounting for a larger proportion of the total prevalent cases around the globe. Some of the key players operating in the market for atopic dermatitis are Astellas Pharma, Anacor Pharmaceuticals Inc., Regeneron Pharmaceuticals, Inc. and Meda AB.

View Report -

https://www.transparencymarketresearch.com/atopic-dermatitis-treatment-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atopic Dermatitis Treatment Market | SWOT Analysis of Major Market Segments here

News-ID: 1112472 • Views: 1816

More Releases from Transparency Market Research

Wireless Mesh Network Market Growth Sales Revenue Analysis 2027
According to a new market report published by Transparency Market Research entitled “Wireless Mesh Network Market (By Radio Frequency Band – sub 1 GHz, 2.4 GHzH, 4.9 GHz and 5 GHz; By Application – Hospitality, Government, Logistics, Mining, Education, Health Care, Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2020 – 2027,” the global wireless mesh network market is expected to reach a value of US$ 11,622.9
The Effects of the COVID-19 Outbreak On Urban Planning Software & Services Marke …
Urban Planning Software & Services Market: Introduction Urban planning software is used to design 3D models of urban environments and plan urban layouts. City planners and architects use urban planning software to conceptualize how urban designs actually look in the real world. Urban planners can enhance urban planning proposals and design layouts for cities by using 3D visualizations according to city zoning rules. Urban planning software is often used by architects,
Impact of Coronavirus (COVID-19) on the Customer Data Platform Market
Global Customer Data Platform Market - Introduction Customer data platform (CDP) is a packaged software that creates a unified, persistent customer database, accessible to other systems. This customer data originates from various sources, to create a particular customer profile. Customer data platform (CDP) provides some functionality of customer engagement and customer behavior. global customer data platform market size and forecast Impact of Coronavirus (COVID-19) on the Customer Data Platform Market Lockdown due to an
IP Geolocation Solutions Market Facts, Figures And Analytical Insights 2027
IP Geolocation Solutions Market: Overview According to a new market report pertaining to the global IP geolocation solutions market published by Transparency Market Research , the global IP geolocation solutions market is projected to reach value of ~US$ 4.5 Bn by 2027. The IP geolocation solutions market is projected to expand at a CAGR of 11% from 2019 to 2027. Expansion of the IP geolocation solutions market can be attributed to

All 5 Releases


More Releases for Atopic

Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2018 - ResearchByMarkets …
"Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H2 2018", provides an overview of the Atopic Dermatitis (Atopic Eczema) (Dermatology) pipeline landscape. Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored patches, itching, which may be severe, especially at night, small, raised bumps, which may leak fluid and crust over when scratched, thickened, cracked or scaly skin and raw, sensitive skin from
Atopic Dermatitis Industry to show steady growth, H2 2017
Overview Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored patches, itching, which may be severe, especially at night, small, raised bumps, which may leak fluid and crust over when scratched, thickened, cracked or scaly skin and raw, sensitive skin from scratching. Risk factors include family history of eczema, allergies, hay fever or asthma and gender.  Click here for sample report @
Recent Research: Atopic Dermatitis Treatment Market Analysis to 2019
Atopic dermatitis (AD) is a type of skin disorder in which the skin becomes dry, itchy and inflamed. Scratching of the skin leads to redness, swelling, scaling, cracking, weeping and crusting. Though, this condition is most common in infants and children, also affects adult population. AD is considered as idiopathic, a disease without a known cause, and is likely to be caused by both genetic as well as environmental factors.
Atopic Dermatitis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Atopic Dermatitis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atopic Dermatitis - Pipeline Review, H2 2017, provides an overview of the Atopic Dermatitis (Dermatology) pipeline landscape. Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownish-gray colored
Global Atopic Dermatitis Treatment Market Research Report 2017
Report Hive Market Research Released a New Research Report of 103 pages on Title " Global Atopic Dermatitis Treatment Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. In this report, the global Atopic Dermatitis Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report
Europe Atopic Dermatitis Drugs Market Report 2017
This report studies sales (consumption) of Atopic Dermatitis Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering LEO Pharma Mylan Valeant Bayer HealthCare Encore Dermatology Fill the form for an exclusive sample of this report @ http://www.qyresearchreports.com/sample/sample.php?rep_id=1020128&type=E Market Segment by Countries, this report splits Europe into several key Countries, with sales